Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

AISym4MED · Synthetic and scalable data platform for medical empowered AI

HORIZONStatus: SIGNED1 December 202230 November 2026EU funding €6,341,765Call HORIZON-HLTH-2022-IND-13

AISym4Med aims at developing a platform that will provide healthcare data engineers, practitioners, and researchers access to a trustworthy dataset system augmented with controlled data synthesis for experimentation and modeling purposes. This platform will address data privacy and security by combining new anonymization techniques, attribute-based privacy measures, and trustworthy tracking systems. Moreover, data quality controlling measures, such as unbiased data and respect to ethical norms, context-aware search, and human-centered design for validation purposes will also be implemented to guarantee the representativeness of the synthetic data generated. Indeed, an augmentation module will be responsible for exploring and developing further the techniques of creating synthetic data, also dynamically on demand for specific use cases. Furthermore, this platform will exploit federated technologies for reproducing un-indentifiable data from closed borders, promoting the indirect assessment of a broader number of databases, while respecting the privacy, security, and GDPR-compliant guidelines. The proposed framework will support the development of innovative unbiased AI-based and distributed tools, technologies, and digital solutions for the benefit of researchers, patients, and providers of health services, while maintaining a high level of data privacy and ethical usage. AISym4Med will help in the creation of more robust machine learning (ML) algorithms for real-world readiness, while considering the most effective computation configuration. Furthermore, a machine-learning meta-engine will provide information on the quality of the generalized model by analyzing its limits and breaking points, contributing to the creation of a more robust system by supplying on-demand real and/or synthetic data. This platform will be validated against local, national, and cross-border use-cases for both data engineers, ML developers, and aid for clinicians’ operations.

Consortium · 16 organisations

coordinator

ASSOCIACAO FRAUNHOFER PORTUGAL RESEARCH

PT · €1,051,553

participant

ZABALA BRUSSELS

BE · €464,375

participant

SAIDOT OY

FI · €548,750

participant

TIMELEX

BE · €417,188

thirdParty

ZABALA INNOVATION CONSULTING SA

ES

associatedPartner

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

UK

participant

INSTRUMENTACION Y COMPONENTES SA

ES · €1,205,000

participant

AYESA IBERMATICA SA

ES · €212,500

thirdParty

Servicio Vasco de Salud Osakidetza

ES

participant

CONSORCIO SANITARIO DE L'ALT PENEDES Y GARRAF (CSAPG)

ES · €498,750

participant

TIGA BILGI TEKNOLOJILERI ANONIM SIRKETI

TR · €394,375

participant

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

NL · €313,100

participant

ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOBIZKAIA

ES · €404,725

associatedPartner

UNIVERSITAT ZURICH

CH

participant

UNIVERSIDADE DO PORTO

PT · €349,755

participant

NOVA ID FCT - ASSOCIACAO PARA A INOVACAO E DESENVOLVIMENTO DA FCT

PT · €481,695

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.